Published in Trials on July 13, 2011
Use of a three-band HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children. Malar J (2014) 1.07
Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS One (2011) 1.03
Contrasting pediatric and adult cerebral malaria: the role of the endothelial barrier. Virulence (2013) 0.96
Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011-2013. Emerg Infect Dis (2015) 0.94
Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial. Malar J (2015) 0.91
In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway. BMC Microbiol (2012) 0.83
Performance of point-of-care diagnostics for glucose, lactate, and hemoglobin in the management of severe malaria in a resource-constrained hospital in Uganda. Am J Trop Med Hyg (2014) 0.81
Vascular dysfunction as a target for adjuvant therapy in cerebral malaria. Mem Inst Oswaldo Cruz (2014) 0.79
Pathophysiological Mechanisms in Gaseous Therapies for Severe Malaria. Infect Immun (2016) 0.79
Endothelial activation, haemostasis and thrombosis biomarkers in Ugandan children with severe malaria participating in a clinical trial. Malar J (2016) 0.76
Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the Brain. Mediators Inflamm (2015) 0.76
Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria. PLoS One (2017) 0.75
Host Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria. Open Forum Infect Dis (2016) 0.75
Methemoglobin and nitric oxide therapy in Ugandan children hospitalized for febrile illness: results from a prospective cohort study and randomized double-blind placebo-controlled trial. BMC Pediatr (2016) 0.75
A better biomarker for cerebral malaria: in the eye of the beheld?*. Crit Care Med (2012) 0.75
Random-effects models for longitudinal data. Biometrics (1982) 54.17
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet (2005) 12.98
Nitric oxide and the immune response. Nat Immunol (2001) 10.00
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52
Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol (1985) 7.14
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science (1999) 6.96
Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med (2006) 5.49
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol (1994) 5.34
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest (1995) 5.09
Grand challenges in global health: community engagement in research in developing countries. PLoS Med (2007) 4.75
A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med (1996) 4.64
Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell (2003) 4.55
Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med (2006) 3.72
Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther (1998) 3.57
Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. Int J Epidemiol (2007) 3.54
A trial of artemether or quinine in children with cerebral malaria. N Engl J Med (1996) 3.28
Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med (2007) 3.13
Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med (1997) 3.13
Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol (2008) 2.85
Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A (2008) 2.80
Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med (1996) 2.75
Trust and informed consent: insights from community members on the Kenyan coast. Soc Sci Med (2005) 2.55
Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics (2007) 2.47
Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics (2008) 2.45
The pathophysiologic and prognostic significance of acidosis in severe adult malaria. Crit Care Med (2000) 2.42
Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy (2005) 2.37
Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol (2008) 2.35
Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ (2007) 2.33
Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med (2006) 2.33
Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood (2009) 2.18
Inhaled nitric oxide therapy in adults. N Engl J Med (2005) 2.04
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One (2009) 1.93
Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics (2003) 1.92
Towards a framework for community engagement in global health research. Trends Parasitol (2010) 1.89
Towards a science of community engagement. Lancet (2006) 1.88
Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet (2003) 1.86
Advances in malaria diagnosis. Expert Rev Anti Infect Ther (2007) 1.84
Severe malaria in children in areas with low, moderate and high transmission intensity in Uganda. Trop Med Int Health (2006) 1.81
Obtaining informed consent in Bangladesh. N Engl J Med (2001) 1.79
Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet (1998) 1.65
Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J (2009) 1.59
von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation. Br J Haematol (2006) 1.55
Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology (1994) 1.55
Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One (2010) 1.43
Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. J Infect Dis (2007) 1.42
Assent in paediatric research: theoretical and practical considerations. J Med Ethics (2006) 1.41
Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis (2001) 1.40
Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev (2006) 1.38
Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog (2010) 1.37
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther (2010) 1.20
Toxicity of nitrogen dioxide: an introduction. Toxicology (1994) 1.14
Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA (2003) 1.11
Cost of nitric oxide is exorbitant. BMJ (2002) 1.10
Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med (1998) 1.08
Nitric oxide bioavailability in malaria. Trends Parasitol (2005) 1.03
Management of severe malaria in children: proposed guidelines for the United Kingdom. BMJ (2005) 1.03
A review of the quality of randomized clinical trials of adjunctive therapy for the treatment of cerebral malaria. Trop Med Int Health (2005) 0.98
Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. Cochrane Database Syst Rev (2003) 0.98
Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review. Bull World Health Organ (2009) 0.96
Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand. J Infect Dis (2002) 0.95
Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis. Am J Hematol (2010) 0.94
Randomized clinical trials in children--ethical and methodological issues. Curr Pharm Des (2010) 0.91
Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population. Am J Trop Med Hyg (2003) 0.86
Statistical quality control in clinical trials. Control Clin Trials (1999) 0.83
The CCTTT pentanucleotide microsatellite in iNOS promoter influences the clinical outcome in P. falciparum infection. Parasitol Res (2009) 0.82
Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears. Antimicrob Agents Chemother (2005) 0.80
Inhaled nitric oxide and the societal perspective. Pediatrics (2004) 0.76
Silo-Filler's disease, the acute respiratory distress syndrome, and oxides of nitrogen. Ann Intern Med (2004) 0.76
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Accuracy of physician self-assessment compared with observed measures of competence: a systematic review. JAMA (2006) 13.17
Mortality after fluid bolus in African children with severe infection. N Engl J Med (2011) 10.99
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med (2005) 7.01
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Secondary active transport mediated by a prokaryotic homologue of ClC Cl- channels. Nature (2004) 5.54
Grand challenges in global health: community engagement in research in developing countries. PLoS Med (2007) 4.75
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep (2013) 3.85
Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med (2010) 3.83
How do I perform a lumbar puncture and analyze the results to diagnose bacterial meningitis? JAMA (2006) 3.81
Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis (2006) 3.69
Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med (2007) 3.64
Illness after international travel. N Engl J Med (2002) 3.56
Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis (2007) 3.53
What type of urinary incontinence does this woman have? JAMA (2008) 3.25
Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis (2002) 3.13
Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers. Am J Trop Med Hyg (2003) 2.75
Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA (2008) 2.69
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2009) 2.66
Malaria hotspot areas in a highland Kenya site are consistent in epidemic and non-epidemic years and are associated with ecological factors. Malar J (2006) 2.65
Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med (2011) 2.59
Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg (2002) 2.55
Structure of a prokaryotic virtual proton pump at 3.2 A resolution. Nature (2009) 2.53
Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics (2007) 2.47
Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics (2008) 2.45
A biological role for prokaryotic ClC chloride channels. Nature (2002) 2.36
From the Cover: A Howiesons Poort tradition of engraving ostrich eggshell containers dated to 60,000 years ago at Diepkloof Rock Shelter, South Africa. Proc Natl Acad Sci U S A (2010) 2.34
Separate ion pathways in a Cl-/H+ exchanger. J Gen Physiol (2005) 2.34
Effectiveness of virtual reality using Wii gaming technology in stroke rehabilitation: a pilot randomized clinical trial and proof of principle. Stroke (2010) 2.28
Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol (2003) 2.25
The phagocytes: neutrophils and monocytes. Blood (2008) 2.25
Small vertical movement of a K+ channel voltage sensor measured with luminescence energy transfer. Nature (2005) 2.18
Improving the diagnosis of acute heart failure using a validated prediction model. J Am Coll Cardiol (2009) 2.18
Malaria. CMAJ (2004) 2.13
Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg (2003) 2.12
Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ (2004) 2.11
Data safety and monitoring boards. N Engl J Med (2004) 2.09
Uncoupling and turnover in a Cl-/H+ exchange transporter. J Gen Physiol (2007) 2.09
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen. J Clin Microbiol (2003) 2.08
NMR study of the tetrameric KcsA potassium channel in detergent micelles. Protein Sci (2006) 2.07
Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol (2005) 2.05
Ionic currents mediated by a prokaryotic homologue of CLC Cl- channels. J Gen Physiol (2004) 2.04
Grand challenges in global health: the ethical, social and cultural program. PLoS Med (2007) 2.02
WHO guidelines on fluid resuscitation in children: missing the FEAST data. BMJ (2014) 2.00
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res (2010) 1.98
Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes. Lancet (2003) 1.98
Arginine-agmatine antiporter in extreme acid resistance in Escherichia coli. J Bacteriol (2003) 1.98
Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis (2011) 1.98
A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion (2002) 1.98
Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study*. Crit Care Med (2012) 1.97
Uncoupling of a CLC Cl-/H+ exchange transporter by polyatomic anions. J Mol Biol (2006) 1.97
Association between total duration of breastfeeding and iron deficiency. Pediatrics (2013) 1.93
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One (2009) 1.93
Electrostatic tuning of ion conductance in potassium channels. Biochemistry (2003) 1.93
Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA (2013) 1.91
Evaluation of the RealArt Malaria LC real-time PCR assay for malaria diagnosis. J Clin Microbiol (2004) 1.91
Synergism between halide binding and proton transport in a CLC-type exchanger. J Mol Biol (2006) 1.90
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion (2002) 1.89
Advances in malaria diagnosis. Expert Rev Anti Infect Ther (2007) 1.84
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA (2003) 1.81
Na+ block and permeation in a K+ channel of known structure. J Gen Physiol (2002) 1.80
Malaria in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis (2004) 1.80
Real-time polymerase chain reaction assay for the rapid detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers. Clin Infect Dis (2006) 1.79
A tough transition. Nature (2007) 1.75
A thermodynamic framework for understanding temperature sensing by transient receptor potential (TRP) channels. Proc Natl Acad Sci U S A (2011) 1.74
Furuncular myiasis: a simple and rapid method for extraction of intact Dermatobia hominis larvae. Clin Infect Dis (2002) 1.73
Molecular diagnostic and surveillance tools for global malaria control. Travel Med Infect Dis (2007) 1.73
The use of nonhuman primate models in HIV vaccine development. PLoS Med (2008) 1.73
Pyruvate kinase deficiency and malaria. N Engl J Med (2008) 1.72
Topography-derived wetness indices are associated with household-level malaria risk in two communities in the western Kenyan highlands. Malar J (2008) 1.70
Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg (2008) 1.69
Ion permeation through a Cl--selective channel designed from a CLC Cl-/H+ exchanger. Proc Natl Acad Sci U S A (2008) 1.67
Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation (2006) 1.67
Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006. Emerg Infect Dis (2008) 1.64
Moving from research ethics review to research ethics systems in low-income and middle-income countries. Lancet (2009) 1.62
A bacterial arginine-agmatine exchange transporter involved in extreme acid resistance. J Biol Chem (2006) 1.61
Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab Invest (2006) 1.60
Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J (2009) 1.59
Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol (2003) 1.57
Complement activation and the resulting placental vascular insufficiency drives fetal growth restriction associated with placental malaria. Cell Host Microbe (2013) 1.57
Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med (2013) 1.57
A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy. J Infect Dis (2007) 1.56
Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One (2011) 1.55
Ineffectiveness of the current strategy to prevent hepatitis A in travelers. J Travel Med (2002) 1.55
Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. J Virol (2003) 1.53
Considerations for the use of human participants in vector biology research: a tool for investigators and regulators. Vector Borne Zoonotic Dis (2015) 1.52
Grand challenges in global health: ethical, social, and cultural issues based on key informant perspectives. PLoS Med (2007) 1.50
Aligning community engagement with traditional authority structures in global health research: a case study from northern Ghana. Am J Public Health (2011) 1.49
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med (2007) 1.49